194 related articles for article (PubMed ID: 10451487)
1. Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma.
Le Bail B; Faouzi S; Boussarie L; Guirouilh J; Blanc JF; Carles J; Bioulac-Sage P; Balabaud C; Rosenbaum J
J Pathol; 1999 Sep; 189(1):46-52. PubMed ID: 10451487
[TBL] [Abstract][Full Text] [Related]
2. Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts.
Blazejewski S; Le Bail B; Boussarie L; Blanc JF; Malaval L; Okubo K; Saric J; Bioulac-Sage P; Rosenbaum J
Am J Pathol; 1997 Sep; 151(3):651-7. PubMed ID: 9284812
[TBL] [Abstract][Full Text] [Related]
3. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
Lau CP; Poon RT; Cheung ST; Yu WC; Fan ST
J Pathol; 2006 Dec; 210(4):459-68. PubMed ID: 17029219
[TBL] [Abstract][Full Text] [Related]
4. In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers.
Hellerbrand C; Bataille F; Schlegel J; Hartmann A; Mühlbauer M; Schölmerich J; Büttner R; Hofstädter F; Bosserhoff AK
Liver Int; 2005 Apr; 25(2):357-66. PubMed ID: 15780062
[TBL] [Abstract][Full Text] [Related]
5. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
[TBL] [Abstract][Full Text] [Related]
6. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
7. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas.
Nakatsukasa H; Ashida K; Higashi T; Ohguchi S; Tsuboi S; Hino N; Nouso K; Urabe Y; Kinugasa N; Yoshida K; Uematsu S; Ishizaki M; Kobayashi Y; Tsuji T
Hepatology; 1996 Jul; 24(1):82-8. PubMed ID: 8707287
[TBL] [Abstract][Full Text] [Related]
8. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
9. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V
Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075
[TBL] [Abstract][Full Text] [Related]
10. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma.
Miao X; Liu G; Xu X; Xie C; Sun F; Yang Y; Zhang T; Hua S; Fan W; Li Q; Huang S; Wang Q; Liu G; Zhong D
Cancer Genet Cytogenet; 2008 Oct; 186(1):25-32. PubMed ID: 18786439
[TBL] [Abstract][Full Text] [Related]
11. The potential role of bcl-2 mRNA and protein exression in hepatocellular carcinomas.
Ravazoula P; Tsamandas AC; Kardamakis D; Gogos C; Karatza C; Thomopoulos K; Tepetes K; Kourelis T; Petsas T; Bonikos DS; Karavias D
Anticancer Res; 2002; 22(3):1799-805. PubMed ID: 12168872
[TBL] [Abstract][Full Text] [Related]
12. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
Gramantieri L; Chieco P; Giovannini C; Lacchini M; Treré D; Grazi GL; Venturi A; Bolondi L
Hum Pathol; 2005 Nov; 36(11):1154-62. PubMed ID: 16260267
[TBL] [Abstract][Full Text] [Related]
13. [Expression of telomerase reverse transcriptase and its relationship with tumor suppressor gene p53 in HCC].
Dai D; Zhai W; Zhu T; Zhu H; Ling Y
Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():79-81. PubMed ID: 11509149
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
[TBL] [Abstract][Full Text] [Related]
15. Difference in gene expression for matrix metalloproteinase-1 between early and advanced hepatocellular carcinomas.
Okazaki I; Wada N; Nakano M; Saito A; Takasaki K; Doi M; Kameyama K; Otani Y; Kubochi K; Niioka M; Watanabe T; Maruyama K
Hepatology; 1997 Mar; 25(3):580-4. PubMed ID: 9049202
[TBL] [Abstract][Full Text] [Related]
16. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K
Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447
[TBL] [Abstract][Full Text] [Related]
17. Cellular distribution of 92-kd type IV collagenase/gelatinase B in human hepatocellular carcinoma.
Ashida K; Nakatsukasa H; Higashi T; Ohguchi S; Hino N; Nouso K; Urabe Y; Yoshida K; Kinugasa N; Tsuji T
Am J Pathol; 1996 Dec; 149(6):1803-11. PubMed ID: 8952517
[TBL] [Abstract][Full Text] [Related]
18. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
19. Expression of interferon alpha/beta receptor in human hepatocellular carcinoma.
Kondo M; Nagano H; Sakon M; Yamamoto H; Morimoto O; Arai I; Miyamoto A; Eguchi H; Dono K; Nakamori S; Umeshita K; Wakasa K; Ohmoto Y; Monden M
Int J Oncol; 2000 Jul; 17(1):83-8. PubMed ID: 10853022
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma.
Masaki T; Tokuda M; Ohnishi M; Watanabe S; Fujimura T; Miyamoto K; Itano T; Matsui H; Arima K; Shirai M; Maeba T; Sogawa K; Konishi R; Taniguchi K; Hatanaka Y; Hatase O; Nishioka M
Hepatology; 1996 Jul; 24(1):72-81. PubMed ID: 8707286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]